OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Increased Siglec-9/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapy
Rong Xiao, Ye Tian, Jiwei Zhang, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 5, pp. 792-804
Closed Access | Times Cited: 12
Rong Xiao, Ye Tian, Jiwei Zhang, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 5, pp. 792-804
Closed Access | Times Cited: 12
Showing 12 citing articles:
Small molecules targeting immune checkpoint proteins for cancer immunotherapy: a patent and literature review (2020-2024)
Qiaohong Geng, Juanjuan Xu, Cheng Du, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Qiaohong Geng, Juanjuan Xu, Cheng Du, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Sophisticated roles of tumor microenvironment in resistance to immune checkpoint blockade therapy in hepatocellular carcinoma
Yizhe Zhang, Yunshu Ma, Ensi Ma, et al.
Cancer Drug Resistance (2025)
Open Access
Yizhe Zhang, Yunshu Ma, Ensi Ma, et al.
Cancer Drug Resistance (2025)
Open Access
The effects of preoperative inflammatory index and immune function on the prognosis of thyroid cancer
Xiaofang Zhang, Feng Liu, Xiaoqin Xu, et al.
Research Square (Research Square) (2025)
Closed Access
Xiaofang Zhang, Feng Liu, Xiaoqin Xu, et al.
Research Square (Research Square) (2025)
Closed Access
Targeting TIME in Advanced Hepatocellular Carcinoma: Mechanisms of Drug Resistance and Treatment Strategies
Xinyi Ye, Xizhu Fang, Fangfang Li, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104735-104735
Closed Access
Xinyi Ye, Xizhu Fang, Fangfang Li, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104735-104735
Closed Access
Carbohydrate Sulfation as a Critical Modulator of Siglec-Sialoglycan Interactions
Jaesoo Jung, Edward N. Schmidt, Matthew S. Macauley
Carbohydrate Research (2025) Vol. 553, pp. 109502-109502
Open Access
Jaesoo Jung, Edward N. Schmidt, Matthew S. Macauley
Carbohydrate Research (2025) Vol. 553, pp. 109502-109502
Open Access
Prunella vulgaris: A potential molecule for the treatment of hepatocellular carcinoma
Jie Lin, Jiaqiang Zhou, K. L. Ye, et al.
Medicine (2025) Vol. 104, Iss. 17, pp. e42267-e42267
Open Access
Jie Lin, Jiaqiang Zhou, K. L. Ye, et al.
Medicine (2025) Vol. 104, Iss. 17, pp. e42267-e42267
Open Access
The progress of natural killer cells in the treatment of immune response to hepatocellular carcinoma
New medicine. (2025), pp. 1-7
Closed Access
New medicine. (2025), pp. 1-7
Closed Access
Sialic Acids: Sweet Modulators Fueling Cancer Cells and Domesticating the Tumor Microenvironment
Jialu Bai, Ruiling Xiao, Jiang De-cheng, et al.
Cancer Letters (2025), pp. 217773-217773
Closed Access
Jialu Bai, Ruiling Xiao, Jiang De-cheng, et al.
Cancer Letters (2025), pp. 217773-217773
Closed Access
Targeting caspase-8: a new strategy for combating hepatocellular carcinoma
Hao Chen, Yumeng Lin, Jie Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Hao Chen, Yumeng Lin, Jie Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
NK cell-based immunotherapy in hepatocellular carcinoma: An attractive therapeutic option for the next decade
Xinyi Wang, Tianye Yang, Xiaoli Shi
Cellular Signalling (2024) Vol. 124, pp. 111405-111405
Closed Access | Times Cited: 1
Xinyi Wang, Tianye Yang, Xiaoli Shi
Cellular Signalling (2024) Vol. 124, pp. 111405-111405
Closed Access | Times Cited: 1
Sialic acid and Siglec receptors in tumor immunity and immunotherapy
Natália Rodrigues Mantuano, Heinz Laübli
Seminars in Immunology (2024) Vol. 74-75, pp. 101893-101893
Open Access | Times Cited: 1
Natália Rodrigues Mantuano, Heinz Laübli
Seminars in Immunology (2024) Vol. 74-75, pp. 101893-101893
Open Access | Times Cited: 1
Comprehensive pan-cancer analysis of KLRB1-CLEC2D pair and identification of small molecule inhibitors to disrupt their interaction
Yaoyao Zhu, Huajie Zhang, Ruoyang Shao, et al.
International Immunopharmacology (2024) Vol. 140, pp. 112908-112908
Closed Access
Yaoyao Zhu, Huajie Zhang, Ruoyang Shao, et al.
International Immunopharmacology (2024) Vol. 140, pp. 112908-112908
Closed Access
Analyzing and Modifying Sialic Acid at the Glycan End: Systematic Review of Methods and Functional Outcomes
Yuan We, Lei Zheng, Ying Chen, et al.
TrAC Trends in Analytical Chemistry (2024), pp. 118083-118083
Closed Access
Yuan We, Lei Zheng, Ying Chen, et al.
TrAC Trends in Analytical Chemistry (2024), pp. 118083-118083
Closed Access
Siglecs-mediated immune regulation in neurological disorders
Hung‐Ya Tu, Limei Yuan, Bo Ni, et al.
Pharmacological Research (2024) Vol. 210, pp. 107531-107531
Open Access
Hung‐Ya Tu, Limei Yuan, Bo Ni, et al.
Pharmacological Research (2024) Vol. 210, pp. 107531-107531
Open Access
Association of SIGLEC9 Expression with Cytokine Expression, Tumor Grading, KRAS, NRAS, BRAF, PIK3CA, AKT Gene Mutations, and MSI Status in Colorectal Cancer
Błażej Ochman, Anna Kot, Sylwia Mielcarska, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 12, pp. 13617-13646
Open Access
Błażej Ochman, Anna Kot, Sylwia Mielcarska, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 12, pp. 13617-13646
Open Access
